144 related articles for article (PubMed ID: 2327773)
1. Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Barriere SL; Albrecht LM; Rybak MJ
Antimicrob Agents Chemother; 1990 Feb; 34(2):257-60. PubMed ID: 2327773
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Barriere SL; Albrecht LM; Rybak MJ
Antimicrob Agents Chemother; 1989 Apr; 33(4):519-21. PubMed ID: 2499251
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
Chambers HF; Xiang Q; Liu ; Chow LL; Hackbarth C
Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
[TBL] [Abstract][Full Text] [Related]
4. Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Barriere SL; Albrecht LM; Rybak MJ
Antimicrob Agents Chemother; 1991 Aug; 35(8):1547-50. PubMed ID: 1929325
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
[TBL] [Abstract][Full Text] [Related]
6. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1997 Aug; 41(8):1662-7. PubMed ID: 9257737
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Kaatz GW; Barriere SL; Schaberg DR; Fekety R
Antimicrob Agents Chemother; 1987 Apr; 31(4):527-30. PubMed ID: 3649202
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Reddy VN; Bailey EM; Rybak MJ
Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
[TBL] [Abstract][Full Text] [Related]
9. CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Lamp KC; Bailey EM; Rybak MJ
Antimicrob Agents Chemother; 1992 Jun; 36(6):1192-7. PubMed ID: 1329613
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Aeschlimann JR; Houlihan HH; Mercier RC; Rybak MJ
Antimicrob Agents Chemother; 1998 Apr; 42(4):981-3. PubMed ID: 9559828
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
Chambers HF; Sande MA
Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
Cantoni L; Glauser MP; Bille J
Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
[TBL] [Abstract][Full Text] [Related]
13. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Aeschlimann JR; Houlihan HH; Mercier RC; Rybak MJ
Antimicrob Agents Chemother; 1998 Feb; 42(2):254-6. PubMed ID: 9527768
[TBL] [Abstract][Full Text] [Related]
16. Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Gilbert M; Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1986 Mar; 29(3):461-3. PubMed ID: 3459391
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
18. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
Sullam PM; Täuber MG; Hackbarth CJ; Chambers HF; Scott KG; Sande MA
Antimicrob Agents Chemother; 1985 May; 27(5):685-7. PubMed ID: 3860185
[TBL] [Abstract][Full Text] [Related]
19. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
Fernández Guerrero ML; de Górgolas M
J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
Hirschl AM; Georgopoulos A; Stanek G; Breyer S; Rotter ML
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):541-8. PubMed ID: 3164157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
